Intradiscal injection of BRTX-100 during an outpatient procedure is expected to alleviate chronic low back pain arising from the damaged disc. The Food and Drug Administration (FDA) has granted Fast ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial evaluating rexlemestrocel-L ...
Data demonstrate progress in each of its MSC-derived programsMELVILLE, N.Y., April 30, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc.
New peer-reviewed study highlights safety and clinical benefits of intradiscal MSC therapy for chronic low back pain from degenerative disc disease. Lumbar disc disease is something we see often in ...
BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX,” or the “Company”) (Nasdaq: BRTX), a late-stage clinical regenerative medicine company focused on stem cell-based therapies and products, today ...
BioRestorative Therapies, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its BRTX-100 program for treating chronic lumbar disc disease (cLDD).
Colorado Rockies designated hitter and former National League MVP Kris Bryant confirmed that he plans to play in 2026 despite repeated back issues and a recent diagnosis of lumbar degenerative disc ...
Verywell Health on MSN
What’s causing your stiff back and how can you relieve it?
Medically reviewed by Theresa Marko, PT, DPT, MS Key Takeaways A stiff back can be caused by everyday factors like muscle strain and poor posture, or by serious issues such as arthritis and spinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results